Key facts
- Two Seas Capital LP filed SCHEDULE 13G for Arbutus Biopharma Corporation Common Shares, without par value (ABUS).
- Disclosed ownership: 5.4%.
- Date of event: 30 Jun 2025.
Two Seas Capital LP - 30 Jun 2025 SCHEDULE 13G Report for Arbutus Biopharma Corporation Common Shares, without par value (ABUS)
- Filing manager
- Two Seas Capital LP
- Reporting owner
- Two Seas Capital LP
- Symbol
- ABUS
- Shares outstanding
- 193,394,759 shares
- Disclosed shares
- 10,443,317 shares
- Ownership percentage
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Aug 2025, 17:40:28 UTC
- Event date
- 30 Jun 2025
- Next filing
- 17 Feb 2026
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
Two Seas Capital LP disclosed 5.4% ownership in Arbutus Biopharma Corporation Common Shares, without par value (ABUS) on 30 Jun 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 17:40.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Two Seas Capital LP | 5.4% | 10,443,317 | 10,443,317 | 0 | /s/ Sina Toussi | Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner | |
| Two Seas Capital GP LLC | 5.4% | 10,443,317 | 10,443,317 | 0 | /s/ Sina Toussi | Sina Toussi / Managing Member | |
| Sina Toussi | 5.4% | 10,443,317 | 10,443,317 | 0 | /s/ Sina Toussi | Sina Toussi |
CIK / CUSIP context first